Drugs / Fluzone® standard IIV3
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03023176 | Sep → Nov 2013 | influenza | Stanford University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluzone standard IIV3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03023176 ↗ |
| Modality | Vaccine | “seasonal trivalent inactivated influenza vaccine (IIV3)” NCT03023176 ↗ |
| Route | Intramuscular | “for Intramuscular Injection” NCT03023176 ↗ |